Literature DB >> 2664695

Amphotericin B in the treatment of Candida cholecystitis.

P C Adamson1, M G Rinaldi, P A Pizzo, T J Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2664695     DOI： 10.1097/00006454-198906000-00030

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

Review 1.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

2.  Candidal liver abscesses and cholecystitis in a 37-year-old patient without underlying malignancy.

Authors:  Chung-Hsu Lai; Hsin-Pai Chen; Te-Li Chen; Chang-Phone Fung; Cheng-Yi Liu; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits.

Authors:  T J Walsh; A J Jackson; J W Lee; M Amantea; T Sein; J Bacher; L Zech
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 4.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Pharmacokinetics of amphotericin B colloidal dispersion in critically ill patients with cholestatic liver disease.

Authors:  Stefan Weiler; Elisabeth Überlacher; Julia Schöfmann; Eva Stienecke; Stefan Dunzendorfer; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

6.  Antifungals: need to search for a new molecular target.

Authors:  A T Sangamwar; U D Deshpande; S S Pekamwar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.